Tonix Pharmaceuticals Holding Corp (TNXP)
0.1578
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
0.16
0.00 (0.00%)
After-Hours: 17:02
Tonix Pharmaceuticals Gross Profit Margin (Quarterly): 37.36% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.36% |
| Date | Value |
|---|---|
| September 30, 2023 | 40.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
37.36%
Minimum
Dec 2023
40.49%
Maximum
Sep 2023
38.93%
Average
38.93%
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 92.26% |
| PetVivo Holdings Inc | 69.28% |
| Acurx Pharmaceuticals Inc | -- |
| Kezar Life Sciences Inc | -- |
| Allakos Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Profit Margin (Quarterly) | -723.0% |
| Operating Margin (Quarterly) | -723.2% |